Greg Hough

Inflammatory/Antiinflammatory Properties of High-Density Lipoprotein Distinguish Patients From Control Subjects Better Than High-Density Lipoprotein Cholesterol Levels and Are Favorably Affected by Simvastatin Treatment

Benjamin J. Ansell, Mohamad Navab, Susan Hama et al. · Circulation · 2003 · 592 citations · Full text

Medicine, Cardiology, Pharmacology +13

Oral Administration of an Apo A-I Mimetic Peptide Synthesized From D-Amino Acids Dramatically Reduces Atherosclerosis in Mice Independent of Plasma Cholesterol

Mohamad Navab, G.M. Anantharamaiah, Susan Hama et al. · Circulation · 2002 · 400 citations

Life Sciences, Biochemistry, Pharmacology +17

Oxygenated Carotenoid Lutein and Progression of Early Atherosclerosis

James H. Dwyer, Mohamad Navab, Kathleen M. Dwyer et al. · Circulation · 2001 · 337 citations · Full text

Agriculture, Nutrition, Nutritional Sciences +15

Oral D-4F Causes Formation of Pre-β High-Density Lipoprotein and Improves High-Density Lipoprotein–Mediated Cholesterol Efflux and Reverse Cholesterol Transport From Macrophages in Apolipoprotein E–Null Mice

Mohamad Navab, G.M. Anantharamaiah, Srinivasa T. Reddy et al. · Circulation · 2004 · 320 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer

Feng Su, Kathy Kozak, Satoshi Imaizumi et al. · Proceedings of the National Academy of Sciences · 2010 · 201 citations

Medicine, Oncology, Pharmacology +15